Form 4: Celldex Therapeutics Director James J. Marino Transfers 10,500 Shares via Gift
SEC Form 4 Filing
Director James J. Marino of Celldex Therapeutics transferred 10,500 shares of common stock as a gift to a family member.
Summary
- James J. Marino, a director at Celldex Therapeutics, gifted 10,500 shares of common stock.
- The transaction occurred on November 18, 2024.
- The shares were transferred to an immediate family member who does not reside in the same household as Mr. Marino.
- Following the transaction, Mr. Marino directly owns 2,204 shares of Celldex Therapeutics stock.
Sentiment
Score: 5
Explanation: The document is a routine SEC Form 4 filing for a stock transfer, which is neutral in sentiment.
Industry Context
This is a routine transaction related to insider ownership and does not indicate any specific trend in the biotechnology industry.
Comparison to Industry Standards
- Insider transactions are common and are regularly reported by directors and officers of publicly traded companies.
- The gift of shares is a personal transaction and does not reflect the company's performance or outlook.
- Similar transactions are seen across the biotechnology sector, with directors often managing their personal holdings.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a personal transfer of shares by a director.
Key Dates
| Date | Description |
|---|---|
| 11/18/2024 | Date of the stock transfer. |
| 11/20/2024 | Date the form was signed. |
Keywords
Celldex Therapeutics, James J. Marino, stock transfer, gift, director, share ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.